AEON

AEON Biopharma, Inc. Class A Common Stock (AEON)

About AEON Biopharma, Inc. Class A Common Stock (AEON)

AEON Biopharma, Inc. is a biopharmaceutical company, which engages in the business of developing proprietary botulinum toxin complex, ABP-450 injection, for debilitating medical conditions. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Irvine, CA.

Details

Daily high

$0.75

Daily low

$0.65

Price at open

$0.74

52 Week High

$64.80

52 Week Low

$0.38

Market cap

8.0M

Dividend yield

0.00%

Volume

233,797

Avg. volume

247,640

P/E ratio

.13

AEON Biopharma, Inc. Class A Common Stock News